New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2013
09:22 EDTINO, HUM, NDAQ, VZ, EZPW, AET, OMPI, BGCP, VOD, AFFY, UNH, HPQ, TOn The Fly: Pre-market Movers
HIGHER: Obagi Medical (OMPI), up 14.9% after Mez Pharma proposes to acquire Obagi for $22 per share... Nuance (NUAN), up 8.5% after Carl Icahn reports 9.27% passive stake... Vodafone (VOD), up 5.2% after FT Alphaville says Verizon (VZ), AT&T (T) may consider offer to break-up and buy Vodafone assets... Humana (HUM), up 9.4%, UnitedHealth (UNH), up 4.2%, Aetna (AET), up 4.2%, after CMS issues final 2014 Medicare Advantage rates that were significantly better than original announcement... BGC Partners (BGCP), up 44.2% after selling treasuries platform to Nasdaq (NDAQ) for up to $1.234B in cash and stock. Nasdaq shares down 5.4% in pre-market after deal announced... ALSO LOWER: Inovio (INO), down 13.3% after collaborator ChronTech reports interim Phase II results from study of vaccine to treat hepatitis C virus... Hewlett-Packard (HPQ), down 4.3% following downgrade to Sell rating at Goldman... EZCORP (EZPW), down 3.1% after downgrade to Underperform at FBR Capital... DOWN AFTER EARNINGS: Affymax (AFFY), down 9.6%.
News For VOD;VZ;T;BGCP;NDAQ;HPQ;OMPI;HUM;UNH;AET;INO;AFFY;EZPW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
May 12, 2015
07:09 EDTVZAOL CEO says will 'certainly' buy Verizon stock
Subscribe for More Information
07:08 EDTVZAOL CEO says company has 'shared vision' with Verizon
Subscribe for More Information
07:06 EDTVZAOL volatility elevated into Verizon acquiring for $4.4B
Subscribe for More Information
07:03 EDTVZVerizon to acquire AOL for $50 per share, an estimated total value of $4.4B
Subscribe for More Information
07:01 EDTVZVerizon to acquire AOL for $50 per share, an estimated total value of $4.4B
Subscribe for More Information
07:01 EDTVZVerizon to acquire AOL for $50 per share, or $4.4B
Subscribe for More Information
06:40 EDTVZVerizon downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded Verizon to Underperform with a $45 price target to reflect a weaker 2016 and 2017 earnings outlook. The firm's analyst believes management has made a series of questionable strategic moves beginning with the Vodafone deal that will depress earnings. Recent advertising promotions are likely to pressure 2015 margins and ARPU and LTE capacity issues are expected in certain markets later in the year. Macquarie is surprised Verizon shares have held in around $50 with treasury yields rising and increasing Q2 promotions and does not believe this is sustainable ahead of a reset in consensus estimates.
06:21 EDTNDAQNASDAQ experimenting with blockchain technology, WSJ reports
Subscribe for More Information
05:32 EDTINOInovio initiates clinical trial with DNA immunotherapies to treat ebola
Subscribe for More Information
May 11, 2015
15:06 EDTAETAetna backs FY15 operating EPS $7.20-$7.40, consensus $7.38
In a regulatory filing earlier, Aetna reported that during upcoming investor meetings in May, the company expects to reaffirm its FY15 operating EPS guidance of $7.20-$7.40. Current FY15 EPS consensus is $7.38.
14:24 EDTVZFrontier announces HSR clearance for acquisition of certain Verizon assets
Subscribe for More Information
12:06 EDTTAT&T appoints Jeffrey Lewis Chief Accessibility Officer
Subscribe for More Information
07:50 EDTHPQHP awarded IT services contract by California WCDS
Subscribe for More Information
07:40 EDTUNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:16 EDTINOInovio reports Q1 EPS (18c), consensus 1c
Subscribe for More Information
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information
06:51 EDTAETAetna management to meet with Leerink
Meeting to be held in Hartford, CT on May 11 hosted by Leerink.
06:05 EDTVZSpherix issued standard-essential patent by USPTO
Spherix (SPEX) announced that the United States Patent & Trademark Office, or USPTO, is issuing the company another standard-essential patent. The company has received from the USPTO an issue notification for patent RE45521, set to issue on May 19. This patent is part of the same family of standard-essential patents currently being litigated against both Cisco (CSCO) and Verizon (VZ). The patented technology relates to the transmittal of data over a network and further enhances the company's existing portfolio.
May 10, 2015
18:05 EDTTFCC contract ruling may speed review of AT&T-DirecTV merger, WSJ says
Subscribe for More Information
13:48 EDTHPQ3D Systems stock may tumble another 30%, Barron's says
Shares of 3D Systems (DDD) could lose another 30% as the company faces development delays, low demand, and the entry of Hewlett-Packard (HPQ) into the market by 2016, Barron's contends in its "Follow Up" column. Barron's maintains its price forecast of $15. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use